A Phase IV Pilot Study to Assess Community-Based Treatment Efficacy in Chronic Hepatitis C Monoinfection and Coinfection With HIV in the District of Columbia
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 08 Aug 2017
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 08 Aug 2017 Results published in the Annals of Internal Medicine
- 29 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 02 Jul 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017.